ImmunoPrecise Antibodies Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From ImmunoPrecise Antibodies Ltd.
After paying $45m upfront, the French firm has beaten off considerable competition to seal the European, Middle East and African rights to tabelecleucel which will be filed next month for Epstein-Barr virus-positive post-transplant lymphoproliferative disease.
Pharma’s latest partnerships focus on Duchenne muscular dystrophy with Precision Biosciences, protein degradation with Seed. Bristol and Schrodinger team in computational drug discovery.
- Contract Manufacturing Organization
- Drug Discovery Tools
- Other Names / Subsidiaries
- BioStrand BV
- BioClue BV
- BioKey BV
- Talem Therapeutics
- U-Protein Express BV
- ModiQuest Research